sulfamoxole Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
anti-infectives, sulfonamides 2520 729-99-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • sulfamoxole
  • oxasulfa
  • sulfabutin
  • sulfadimethyloxazole
  • sulfamoxolum
  • sulfmidil
  • tardamide
  • tardamid
A sulfanilamide antibacterial agent.
  • Molecular weight: 267.30
  • Formula: C11H13N3O3S
  • CLOGP: 0.50
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 2
  • TPSA: 98.22
  • ALOGS: -3
  • ROTB: 2

Drug dosage:

DoseUnitRoute
1 g O
1 g P

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

SourceCodeDescription
ATC J01EC03 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
SULFONAMIDES AND TRIMETHOPRIM
Intermediate-acting sulfonamides
ATC J01EE04 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
SULFONAMIDES AND TRIMETHOPRIM
Combinations of sulfonamides and trimethoprim, incl. derivatives
MeSH PA D000890 Anti-Infective Agents
CHEBI has role CHEBI:49103 drug metabolites
CHEBI has role CHEBI:33281 antibiotics
CHEBI has role CHEBI:88188 allergenic drug

Drug Use (View source of the data)

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 7.54 acidic
pKa2 2.18 Basic
pKa3 0.73 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
N0000166868 NUI
D02516 KEGG_DRUG
4017765 VANDF
C0006463 UMLSCUI
CHEBI:55548 CHEBI
CHEMBL2105399 ChEMBL_ID
D013423 MESH_DESCRIPTOR_UI
DB08798 DRUGBANK_ID
1277 INN_ID
HGG82XE020 UNII
12894 PUBCHEM_CID
10183 RXNORM
5531 MMSL
7990 MMSL
d00120 MMSL
002818 NDDF
005294 NDDF
372858002 SNOMEDCT_US
50848005 SNOMEDCT_US
80732005 SNOMEDCT_US

Pharmaceutical products:

None